Pharmacogenomics of Pain Management

Piotr K. Janicki

doi:10.1007/978-1-4939-1818-8_2

Pharmacogenomics of Pain Management

Piotr K. Janicki

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Scopus citations

Abstract

Medicine has been continuously challenged, as well as stimulated, by the extraordinary variability in patient response to pharmacotherapy. The new age of identification of risk factors associated with pharmacotherapy using the methods of molecular medicine focuses on generating predictions regarding clinical outcome on the basis of each individual’s unique DNA sequence. This new field has been coined pharmacogenomics. The goal of pharmacogenomics is to use information provided by advances in human genetics to identify patients at risk for significantly altered response during pharmacotherapy. The field of pharmacogenomics represents the major drive behind the introduction of the concept of personalized medicine in which the medical treatment is customized according to the individual patient genomic signature.

Original language	English (US)
Title of host publication	Treatment of Chronic Pain by Medical Approaches the American Academy of Pain Medicine Textbook on Patient Management
Publisher	Springer New York
Pages	21-31
Number of pages	11
ISBN (Electronic)	9781493918188
ISBN (Print)	9781493918171
DOIs	https://doi.org/10.1007/978-1-4939-1818-8_2
State	Published - Jan 1 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1007/978-1-4939-1818-8_2

Cite this

@inbook{62eb77b9e049402d948bf84b5c697daa,

title = "Pharmacogenomics of Pain Management",

abstract = "Medicine has been continuously challenged, as well as stimulated, by the extraordinary variability in patient response to pharmacotherapy. The new age of identification of risk factors associated with pharmacotherapy using the methods of molecular medicine focuses on generating predictions regarding clinical outcome on the basis of each individual{\textquoteright}s unique DNA sequence. This new field has been coined pharmacogenomics. The goal of pharmacogenomics is to use information provided by advances in human genetics to identify patients at risk for significantly altered response during pharmacotherapy. The field of pharmacogenomics represents the major drive behind the introduction of the concept of personalized medicine in which the medical treatment is customized according to the individual patient genomic signature.",

author = "Janicki, \{Piotr K.\}",

note = "Publisher Copyright: {\textcopyright} American Academy of Pain Medicine 2015.",

year = "2014",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-1818-8\_2",

language = "English (US)",

isbn = "9781493918171",

pages = "21--31",

booktitle = "Treatment of Chronic Pain by Medical Approaches the American Academy of Pain Medicine Textbook on Patient Management",

publisher = "Springer New York",

address = "United States",

}

TY - CHAP

T1 - Pharmacogenomics of Pain Management

AU - Janicki, Piotr K.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Medicine has been continuously challenged, as well as stimulated, by the extraordinary variability in patient response to pharmacotherapy. The new age of identification of risk factors associated with pharmacotherapy using the methods of molecular medicine focuses on generating predictions regarding clinical outcome on the basis of each individual’s unique DNA sequence. This new field has been coined pharmacogenomics. The goal of pharmacogenomics is to use information provided by advances in human genetics to identify patients at risk for significantly altered response during pharmacotherapy. The field of pharmacogenomics represents the major drive behind the introduction of the concept of personalized medicine in which the medical treatment is customized according to the individual patient genomic signature.

AB - Medicine has been continuously challenged, as well as stimulated, by the extraordinary variability in patient response to pharmacotherapy. The new age of identification of risk factors associated with pharmacotherapy using the methods of molecular medicine focuses on generating predictions regarding clinical outcome on the basis of each individual’s unique DNA sequence. This new field has been coined pharmacogenomics. The goal of pharmacogenomics is to use information provided by advances in human genetics to identify patients at risk for significantly altered response during pharmacotherapy. The field of pharmacogenomics represents the major drive behind the introduction of the concept of personalized medicine in which the medical treatment is customized according to the individual patient genomic signature.

UR - https://www.scopus.com/pages/publications/105009136081

UR - https://www.scopus.com/pages/publications/105009136081#tab=citedBy

U2 - 10.1007/978-1-4939-1818-8_2

DO - 10.1007/978-1-4939-1818-8_2

M3 - Chapter

AN - SCOPUS:105009136081

SN - 9781493918171

SP - 21

EP - 31

BT - Treatment of Chronic Pain by Medical Approaches the American Academy of Pain Medicine Textbook on Patient Management

PB - Springer New York

ER -

Pharmacogenomics of Pain Management

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this